Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.

Saez-Llorens X, Violari A, Ndiweni D, Yogev R, Cashat M, Wiznia A, Chittick G, Harris J, Hinkle J, Blum MR, Adda N, Rousseau F; FTC-203 Study Team.

Pediatrics. 2008 Apr;121(4):e827-35. doi: 10.1542/peds.2006-3078. Epub 2008 Mar 10.

PMID:
18332076
[PubMed - indexed for MEDLINE]
Free Article
2.

Efficacy and safety of once-daily regimens in the treatment of HIV infection.

Molina JM.

Drugs. 2008;68(5):567-78. Review.

PMID:
18370438
[PubMed - indexed for MEDLINE]
3.

Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy.

Cahn P.

Expert Opin Investig Drugs. 2004 Jan;13(1):55-68. Review.

PMID:
14680453
[PubMed - indexed for MEDLINE]
4.

Initiation of antiretroviral therapy: implications of recent findings.

Saag MS.

Top HIV Med. 2004 Jul-Aug;12(3):83-8. Review.

PMID:
15310939
[PubMed - indexed for MEDLINE]
Free Article
5.

Emtricitabine: a novel nucleoside reverse transcriptase inhibitor.

Molina JM, Cox SL.

Drugs Today (Barc). 2005 Apr;41(4):241-52. Review.

PMID:
16034488
[PubMed - indexed for MEDLINE]
6.

Didanosine enteric-coated capsule: current role in patients with HIV-1 infection.

Moreno S, Hernández B, Dronda F.

Drugs. 2007;67(10):1441-62. Review.

PMID:
17600392
[PubMed - indexed for MEDLINE]
7.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.

PMID:
18677028
[PubMed - indexed for MEDLINE]
8.

Emtricitabine: an antiretroviral agent for HIV infection.

Bang LM, Scott LJ.

Drugs. 2003;63(22):2413-24; discussion 2425-6. Review.

PMID:
14609348
[PubMed - indexed for MEDLINE]
9.

Integrase inhibitors: a novel class of antiretroviral agents.

Schafer JJ, Squires KE.

Ann Pharmacother. 2010 Jan;44(1):145-56. doi: 10.1345/aph.1M309. Epub 2009 Dec 29. Review.

PMID:
20040702
[PubMed - indexed for MEDLINE]
10.

Pharmacologic perspectives for once-daily antiretroviral therapy.

Anderson PL.

Ann Pharmacother. 2004 Nov;38(11):1924-34. Epub 2004 Oct 12. Review.

PMID:
15479772
[PubMed - indexed for MEDLINE]
11.

Emtricitabine: a review of its use in the management of HIV infection.

Frampton JE, Perry CM.

Drugs. 2005;65(10):1427-48. Review.

PMID:
15977972
[PubMed - indexed for MEDLINE]
12.

Emtricitabine/tenofovir disoproxil fumarate.

Dando TM, Wagstaff AJ.

Drugs. 2004;64(18):2075-82; discussion 2083-4. Review.

PMID:
15341498
[PubMed - indexed for MEDLINE]
13.

Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor.

Modrzejewski KA, Herman RA.

Ann Pharmacother. 2004 Jun;38(6):1006-14. Epub 2004 Apr 30. Review.

PMID:
15121999
[PubMed - indexed for MEDLINE]
14.

Adherence to high activity antiretrovial therapy (HAART) in pediatric patients infected with HIV: issues and interventions.

Shah CA.

Indian J Pediatr. 2007 Jan;74(1):55-60. Review.

PMID:
17264455
[PubMed - indexed for MEDLINE]
15.

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

Chetchotisakd P.

Expert Rev Anti Infect Ther. 2009 Sep;7(7):801-5. doi: 10.1586/eri.09.66. Review.

PMID:
19735222
[PubMed - indexed for MEDLINE]
16.

Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.

Wainberg MA, Cahn P, Bethell RC, Sawyer J, Cox S.

Antivir Chem Chemother. 2007;18(2):61-70. Review.

PMID:
17542150
[PubMed - indexed for MEDLINE]
17.

Emtricitabine (FTC) for the treatment of HIV infection.

Nelson M, Schiavone M.

Int J Clin Pract. 2004 May;58(5):504-10. Review.

PMID:
15206508
[PubMed - indexed for MEDLINE]
18.

Impact of once- and twice-daily dosing regimens on adherence and overall safety.

Hawkins T.

AIDS Read. 2004 Jun;14(6):320-2, 324, 329-31, 334-6. Review.

PMID:
15243968
[PubMed - indexed for MEDLINE]
19.

Recommendations in pediatric antiretroviral therapy.

Ikeda T, Ch'ng TW, Oleske JM.

Expert Opin Pharmacother. 2007 Feb;8(2):155-66. Review.

PMID:
17257086
[PubMed - indexed for MEDLINE]
20.

Antiretroviral drugs in pediatrics.

Rongkavilit C, Asmar BI.

Indian J Pediatr. 2001 Jul;68(7):641-7. Review.

PMID:
11519288
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk